Back
Regeneron Pharmaceuticals Stock Predictions
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$527.47
Seasonality Move:
8.37%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 30.7% based on the past 34 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $527.78. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 30.7% based on the past 34 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
520.50
Prediction Charts
Market Cap:
57B
Price in USD:
527.78
Volume:
1.5M
Beta:
0.95
Technical Analysis
SMA50:
619.49
SMA100:
661.05
SMA200:
830.42
52-Wk Change:
-45.48%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 527.78 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 565.50 | 585.49 | 587.10 | 565.14 |
| Apr-23 | 595.87 | 587.85 | 603.77 | 584.45 |
| Apr-24 | 590.93 | 599.76 | 601.28 | 586.81 |
| Apr-25 | 598.33 | 602.64 | 602.79 | 585.78 |
| Apr-28 | 603.36 | 610.86 | 614.83 | 601.19 |
| Apr-29 | 561.75 | 568.91 | 579.98 | 542.44 |
| Apr-30 | 579.26 | 598.76 | 600.20 | 566.99 |
| May-1 | 589.77 | 590.00 | 593.94 | 578.50 |
| May-2 | 600.00 | 605.61 | 615.61 | 599.08 |
| May-5 | 606.89 | 603.58 | 611.04 | 601.81 |
| May-6 | 601.01 | 558.52 | 606.87 | 557.64 |
| May-7 | 561.79 | 560.93 | 568.13 | 556.36 |
| May-8 | 547.88 | 547.67 | 552.57 | 520.50 |
| May-9 | 549.00 | 527.78 | 552.84 | 527.13 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $1.40 per share, an increase next quarter of $0.06 per share, a decrease this year of $9.13 per share, and an increase next year of $4.61 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.